WEDNESDAY, April 19, 2023 (HealthDay News) — Summer is almost here, and its arrival brings opportunities for many people – including those who suffer with allergies and asthma — to plan vacations away from home. A recent article titled “Allergies don’t take a vacation” in Annals of Allergy, Asthma &Continue Reading
TUESDAY, April 18, 2023 (HealthDay News) — Seniors and people with weakened immune systems can get another booster dose of the bivalent COVID vaccine this spring, the U.S. Food and Drug Administration announced Tuesday. Seniors age 65 and older can get a booster at least four months following their firstContinue Reading
TUESDAY, April 18, 2023 (HealthDay News) — Offering medications for opioid use disorder to prisoners could mean fewer overdose deaths later, new research suggests. “Offering medications for opioid addiction for incarcerated individuals saves lives. Specifically, offering all three medications — buprenorphine, methadone, and naltrexone — is the most effective atContinue Reading
MONDAY, April 17, 2023 (HealthDay News) — Arthritis is a common disease that causes pain and inflammation in different body joints, making it difficult to enjoy everyday tasks and physical activity. Fortunately, there are many different medications for arthritis. Depending on what type of arthritis you have and its severity,Continue Reading
THURSDAY, April 13, 2023 (HealthDay News) — As people with HIV live longer they’re at risk of premature heart disease. But a new study finds statin drugs can cut the risk of serious heart problems by more than one-third. The U.S. National Institutes of Health trial found the cholesterol-lowering drugsContinue Reading
WEDNESDAY, April 12, 2023 (HealthDay News) — U.S. officials are intensifying efforts to crack down on illicit use of the veterinary tranquilizer xylazine, which can cause painful and deadly side effects in humans. The drug, when mixed with the opioid fentanyl, has been designated an “emerging threat,” the Office ofContinue Reading
WEDNESDAY, April 12, 2023 (HealthDay News) — The United States is in the middle of an opioid crisis, yet new research shows that only about 7% of Americans on Medicaid who have opioid use disorder receive residential treatment. This means that many people who could potentially benefit from what isContinue Reading
TUESDAY, April 11, 2023 (HealthDay News) — Over the past few years the escalating opioid crisis has touched off a complex debate about how best to reign in suicide risk among patients who are prescribed the addictive painkillers. The question: Could rapidly cutting back on legal opioid prescriptions help, orContinue Reading
TUESDAY, April 11, 2023 (HealthDay News) — In the early days of the mpox virus outbreak in the United States, vaccines got to the states that needed them but distribution was unequal across racial groups, new research reveals. Black and Hispanic patients had to travel significantly farther for doses thanContinue Reading
THURSDAY, April 6, 2023 (HealthDay News) — An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show. The vaccine is 86% effective in protecting older adults against RSV infections severe enough to cause three or more symptoms, according to findingsContinue Reading